MCKECHNIE DUNCAN (EVP, Chief Commercial Officer) sold 17.4% of their position (2.63K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $1.31M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/13/2026ACC: 0000875320-26-000138
Officer· EVP, Chief Commercial Officer
Since Mar 2026
-2.63K
Net shares
Net seller
$1.31M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.63K
Price / share
$498.42
Trade value
$1.31M
% of position
17.4%
3/11/2026
15.12K→12.49K
Total
Net shares
−2.63K
Net value
-$1.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2026 | S · Sale | −2.63K | $498.42 | $1.31M | 17.4% | 15.12K | 12.49K |
| Total | −2.63K | -$1.31M | ||||||
Derivative Transactions0
No derivative transactions reported